申请人:Pfizer Inc.
公开号:US04554276A1
公开(公告)日:1985-11-19
Novel 2-amino-5-hydroxy-4-methylpyrimidines and substituted amino derivatives thereof useful as inhibitors of leukotriene synthesis for the treatment of pulmonary, inflammatory and cardiovascular diseases, cancer and psoriasis. In addition these compounds are cytoprotective and therefore useful in the treatment of peptic ulcers. A process for the preparation of such active compounds by ring rearrangement of 2-amino-5-acetyloxazole, pharmaceutical compositions containing the novel active compounds and compositions containing these compounds in combination with other anti-inflammatory agents or gastric anti-secretory agents.
新型2-氨基-5-羟基-4-甲基嘧啶及其取代氨基衍生物可用作白三烯合成抑制剂,用于治疗肺部、炎症性和心血管疾病、癌症和牛皮癣。此外,这些化合物具有细胞保护作用,因此可用于治疗消化性溃疡。通过对2-氨基-5-乙酰氧唑环重排制备这种活性化合物的方法,制备含有这些新型活性化合物的药物组合物以及含有这些化合物与其他抗炎药物或胃抑酸药物组合的组合物。